Etubics
Seattle
About Etubics
Etubics Corporation is a Seattle based biopharmaceutical company developing targeted immunotherapies and vaccine products for a wide range of resilient diseases. Etubics patent-protected technology has been proven to be safer, more efficient and more effective than current vectored vaccines and gene delivery platforms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.4M
- Last round: Series Unknown (Apr 2014)
- Website: etubics.com
- Phone: 2068382978
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/etubics-2843878 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.